GMR Infra set to bag Rs 1,500-cr Andhra highway project

08 Nov 2011

1

GMR Infrastructure is close to winning a Rs 1,500-crore highway project, connecting Hyderabad with Sangareddy in Andhra Pradesh.

A decision to award the toll-based project will be taken this month, the Business Standard newspaper reporte, quoting unnamed National Highways Authority of India (NHAI) officials.

A company spokesperson declined to comment.

According to NHAI officials, this project is part of a larger 245-km highway development project connecting Hyderabad and Solapur.

The decision to award the contract for this 145-km-long toll-road project will be taken this month.

The highways division is the third main arm of GMR Infra, bringing in less than 10 per cent of the total top line of around Rs6,000 crore.

Latest articles

Sigma Advanced to acquire UK aerospace supplier Bromford for ₹153 crore

Sigma Advanced to acquire UK aerospace supplier Bromford for ₹153 crore

Akasa Air plans ₹1,050 crore fundraising to support growth amid higher costs

Akasa Air plans ₹1,050 crore fundraising to support growth amid higher costs

AI startup Reflection signs over $1 billion computing deal with Nebius

AI startup Reflection signs over $1 billion computing deal with Nebius

Tata Power explores $450 million overseas loan for business operations

Tata Power explores $450 million overseas loan for business operations

TCS wins technology contract for New York JFK Airport’s $19 billion terminal

TCS wins technology contract for New York JFK Airport’s $19 billion terminal

South Korean firms unveil $195 billion investment in AI and advanced industries

South Korean firms unveil $195 billion investment in AI and advanced industries

HCLTech wins $1.14 billion AI transformation deal with European client

HCLTech wins $1.14 billion AI transformation deal with European client

Microsoft launches Frontier to help enterprises accelerate AI adoption

Microsoft launches Frontier to help enterprises accelerate AI adoption

AstraZeneca signs up to $1.77 billion CSPC deal for kidney disease drugs

AstraZeneca signs up to $1.77 billion CSPC deal for kidney disease drugs